Status:
COMPLETED
Effects of Intermittent Fasting on Polycystic Ovary Syndrome (PCOS) Compared to Standard Treatment
Lead Sponsor:
Instituto Superior de Investigación en Estética Médica, Nutrición y Anti-Envejecimiento
Collaborating Sponsors:
Centro Medico ABC
Conditions:
Polycystic Ovary Syndrome
Insulin Resistance
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the effects of Time restricted eating in patients diagnosed with polycystic ovary syndrome, comparing it to the standard hormonal treatment.
Detailed Description
After being informed about the study and potential risks, all patients were given a written informed consent. Patients were recruited through social media and digital questionnaires, to make sure they...
Eligibility Criteria
Inclusion
- Age: 20 - 35 years
- Mild to moderate exercise at least 4 times per week
- Body Mass Index (BMI) of 20-24.9
- Diagnosis of PCOS by Rotterdam criteria
- Type of oral contraceptives: combined (estrogens and progestins) in group 1 and 2.
- PCOS Phenotype A, B, C
- nulliparity
- Signed informed consent letter
Exclusion
- Menopause or perimenopause
- Night work shifts
- Phenotype D (without hyperandrogenism)
- Associated pathologies such as diabetes mellitus, arterial hypertension, metabolic syndrome, neoplasms, autoimmune diseases.
- Intake of medications on a regular basis, not including oral contraceptives for group 1 and 2.
Key Trial Info
Start Date :
June 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06031753
Start Date
June 3 2021
End Date
October 11 2022
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Médico ABC
Mexico City, Mexico, 05300